Davunetide (NAP) as a preventative treatment for central nervous system complications in a diabetes rat model. [electronic resource]
Producer: 20120206Description: 327-39 p. digitalISSN:- 1095-953X
- Animals
- Caspase 3 -- metabolism
- Central Nervous System Diseases -- etiology
- Cognition Disorders -- drug therapy
- Diabetes Mellitus, Experimental -- complications
- Disease Models, Animal
- Lectins -- metabolism
- Magnetic Resonance Imaging -- methods
- Male
- Maze Learning -- drug effects
- Mental Disorders -- drug therapy
- Neuroprotective Agents -- therapeutic use
- Oligopeptides -- therapeutic use
- Phosphopyruvate Hydratase -- metabolism
- Rats
- Rats, Sprague-Dawley
- Reaction Time -- drug effects
- Social Behavior
- Space Perception -- drug effects
- Synaptophysin -- metabolism
- Time Factors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.